| Literature DB >> 29216835 |
Samantha Assis de Aguiar1, Samires Avelino de Souza França1, Barbara Brasil Santana1, Mike Barbosa Santos1, Felipe Bonfim Freitas1, Glenda Ferreira1, Izaura Cayres-Vallinoto1, Marluísa O G Ishak1, Ricardo Ishak1, Antonio Carlos Rosário Vallinoto2.
Abstract
BACKGROUND: This cross-sectional study evaluated the prevalence of infection with human T-lymphotropic virus 1 and 2 (HTLV-1 and HTLV-2) in a population from the municipalities of Anajás, Chaves, São Sebastião da Boa Vista (SSBV) and Portel in the Marajó Archipelago and correlated these data with the epidemiological characteristics of the study population.Entities:
Keywords: Epidemiology; HTLV-1aA; Marajó Island
Mesh:
Substances:
Year: 2017 PMID: 29216835 PMCID: PMC5721473 DOI: 10.1186/s12879-017-2859-x
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Sociodemographic characteristics of the residents of the municipalities studied. Marajó archipelago, Pará, Brazil
| Sociodemographic | SSBV | Anajás | Portel | Chaves | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| Gender | ||||||||||
| Female | 258 | (72.07) | 240 | (67.80) | 533 | (67.81) | 273 | (73.78) | 1304 | (69.81) |
| Male | 100 | (27.93) | 114 | (32.20) | 253 | (32.19) | 97 | (26.22) | 564 | (30.19) |
| NR* | 5 | 3 | 6 | 7 | 31 | |||||
| Age group | ||||||||||
| 0–10 | 97 | (27.09) | 83 | (23.99) | 196 | (25.13) | 73 | (17.72) | 449 | (26.04) |
| 11–20 | 53 | (14.80) | 60 | (17.34) | 150 | (19.23) | 83 | (20.15) | 346 | (20.07) |
| 21–30 | 46 | (12.85) | 60 | (17.34) | 111 | (14.23) | 56 | (13.59) | 273 | (15.84) |
| 31–40 | 60 | (16.76) | 44 | (12.72) | 117 | (15.00) | 55 | (13.35) | 276 | (16.01) |
| 41–50 | 43 | (12.01) | 36 | (10.40) | 72 | (9.23) | 40 | (9.71) | 191 | (11.08) |
| 51–60 | 28 | (7.82) | 31 | (8.96) | 67 | (8.59) | 38 | (9.22) | 164 | (9.51) |
| > 61 | 31 | (8.66) | 32 | (9.25) | 67 | (8.59) | 25 | (16.26) | 155 | (1.45) |
| NR* | 15 | 11 | 12 | 7 | 45 | |||||
| Marital status | ||||||||||
| Married | 138 | (62.16) | 117 | (50.21) | 281 | (48.36) | 136 | (40.12) | 672 | (52.01) |
| Separated | 5 | (2.25) | 14 | (6.01) | 31 | (5.34) | 3 | (0.88) | 53 | (4.10) |
| Single | 64 | (28.83) | 87 | (37.34) | 238 | (40.96) | 169 | (49.85) | 558 | (43.19) |
| Widowed | 15 | (6.76) | 15 | (6.44) | 31 | (5.34) | 9 | (9.14) | 70 | (0.70) |
| NR* (< 18 years) | 151 | 124 | 211 | 60 | 546 | |||||
| Educational level | ||||||||||
| Illiterate | 33 | (10.68) | 50 | (19.23) | 153 | (21.46) | 37 | (10.69) | 273 | (16.59) |
| Literate | 190 | (61.49) | 132 | (50.77) | 397 | (55.68) | 186 | (53.76) | 905 | (54.98) |
| Primary education | 38 | (12.30) | 39 | (15.00) | 79 | (11.08) | 59 | (17.05) | 215 | (13.06) |
| Secondary education | 33 | (10.68) | 29 | (11.05) | 74 | (10.38) | 44 | (12.72) | 180 | (10.94) |
| Higher education | 15 | (4.85) | 10 | (3.85) | 28 | (1.40) | 20 | (5.78) | 73 | (4.43) |
| NR* | 64 | 97 | 61 | 31 | 253 | |||||
| Family income | ||||||||||
| < 1 minimum monthly wage | 160 | (52.81) | 120 | (44.28) | 165 | (22.57) | 113 | (33.93) | 558 | (34.07) |
| 1–3 minimum monthly wage | 140 | (46.20) | 148 | (54.61) | 540 | (73.87) | 211 | (63.36) | 1039 | (63.43) |
| ≥ 4 minimum monthly wage | 3 | (0.99) | 3 | (1.11) | 26 | (3.56) | 9 | (2.70) | 41 | (2.50) |
| NR* | 70 | 86 | 61 | 44 | 261 | |||||
* NR: not reported
Risk factors of the population older than 11 years of age in the municipalities studied
| Risk factors | SSBV | Anajás | Portel | Chaves | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| Do you know what STDs are? | ||||||||||
| No | 127 | (58.80) | 142 | (67.62) | 287 | (57.06) | 146 | (56.15) | 702 | (59.04) |
| Yes | 89 | (41.20) | 68 | (32.38) | 216 | (42.94) | 114 | (43.85) | 487 | (40.96) |
| NR* | 60 | 64 | 93 | 44 | 261 | |||||
| Do you use condoms? | ||||||||||
| Always | 43 | (20.00) | 53 | (25.73) | 112 | (23.58) | 59 | (24.08) | 267 | (23.40) |
| Never | 106 | (49.30) | 94 | (45.63) | 204 | (42.95) | 93 | (37.96) | 497 | (43.56) |
| Sometimes | 66 | (30.70) | 59 | (28.64) | 159 | (33.47) | 93 | (37.96) | 377 | (33.04) |
| NR* | 61 | 68 | 121 | 59 | 309 | |||||
| Do you have a steady partner? | ||||||||||
| Yes | 162 | (75.00) | 162 | (76.42) | 367 | (77.59) | 186 | (75.92) | 877 | (76.53) |
| No | 54 | (25.00) | 50 | (23.58) | 106 | (22.41) | 59 | (24.08) | 269 | (23.47) |
| NR* | 60 | 62 | 123 | 59 | 304 | |||||
| Sexual orientation | ||||||||||
| Homosexual | 3 | (1.33) | 18 | (8.87) | 23 | (4.80) | 5 | (2.03) | 49 | (4.25) |
| Heterosexual | 221 | (98.22) | 184 | (90.64) | 452 | (94.36) | 240 | (97.56) | 1097 | (95.14) |
| Bisexual | 1 | (0.44) | 1 | (0.49) | 4 | (0.84) | 1 | (0.41) | 7 | (0.61) |
| NR* | 51 | 71 | 117 | 58 | 297 | |||||
| Do you use illicit drugs? | ||||||||||
| Yes | 6 | (3.24) | 15 | (6.79) | 17 | (3.70) | 5 | (1.91) | 43 | (3.81) |
| No | 179 | (96.76) | 206 | (93.21) | 443 | (96.30) | 257 | (98.09) | 1085 | (96.19) |
| NR* | 91 | 53 | 136 | 42 | 322 | |||||
| Are you sexually active? | ||||||||||
| Yes | 173 | (74.25) | 166 | (71.86) | 391 | (73.36) | 211 | (77.29) | 941 | (74.09) |
| No | 60 | (25.75) | 65 | (28.14) | 142 | (26.64) | 62 | (22.71) | 329 | (25.91) |
| NR* | 43 | 43 | 63 | 31 | 180 | |||||
| Age of sexual debut | ||||||||||
| 10–15 years | 68 | (31.63) | 82 | (40.59) | 184 | (39.48) | 98 | (41.18) | 432 | (38.54) |
| 16–20 years | 121 | (56.28) | 100 | (49.50) | 249 | (53.43) | 125 | (52.52) | 595 | (53.08) |
| 21–25 years | 20 | (9.30) | 17 | (8.42) | 28 | (6.01) | 11 | (4.62) | 76 | (6.78) |
| > 25 years | 6 | (2.79) | 3 | (1.49) | 5 | (1.07) | 4 | (1.68) | 18 | (1.61) |
| NR* | 61 | 72 | 130 | 66 | 329 | |||||
| Sex with sex workers | ||||||||||
| Yes | 8 | (4.08) | 20 | (9.90) | 29 | (6.58) | 14 | (5.88) | 71 | (6.59) |
| No | 188 | (95.92) | 182 | (90.10) | 412 | (93.42) | 224 | (94.12) | 1006 | (93.41) |
| NR* | 80 | 72 | 155 | 66 | 373 | |||||
* NR: not reported
Serological profile for anti-HTLV-1/2 in Marajó Archipelago, Pará, Brazil
| Municipality | Subjects | ELISA | |||
|---|---|---|---|---|---|
| Record | Age | Gender | Signal-to-cutoff ratio | Results | |
| SSBV | 366 | 91 | F | 1.385 | Positive |
| SSBV | 171 | 19 | F | 1.000 | Indeterminate |
| SSBV | 237 | 10 | M | 0.922 | Indeterminate |
| SSBV | 256 | 16 | F | 0.907 | Indeterminate |
| SSBV | 701 | 15 | F | 1.003 | Indeterminate |
| SSBV | 274 | 2 | F | 0.917 | Indeterminate |
| Anajás | 152 | 38 | F | 1.323 | Positive |
| Anajás | 243 | 37 | M | 1.403 | Positive |
| Anajás | 303 | 31 | F | 1.919 | Positive |
| Anajás | 117 | 48 | F | 0.905 | Indeterminate |
| Anajás | 168 | 14 | F | 0.906 | Indeterminate |
| Anajás | 169 | 16 | F | 0.948 | Indeterminate |
| Portel | 508 | 7 | M | 1.363 | Positive |
| Portel | 688 | 22 | M | 3.100 | Positive |
| Chaves | 146 | 53 | F | 2.740 | Positive |
| Chaves | 167 | 46 | F | 2.243 | Positive |
| Chaves | 180 | 31 | F | 1.399 | Positive |
| Chaves | 246 | 7 | M | 2.713 | Positive |
| Chaves | 504 | 18 | M | 3.213 | Positive |
SSBV São Sebastião da Boa Vista; Cut-off = 1.000
Fig. 1Rooted phylogenetic tree, showing the evolutionary relationship of human T-lymphotropic virus 1 strains described thus far including newly sequenced isolates from the present study BRPA_146 [MG321560] and BRPA_180 [MG321561]). The tree was constructed by the Bayesian method after alignment of 437 nucleotides of the 5’LTR region. The Mel5 isolate was used as outgroup. The statistical support was applied using 1000 bootstrap replicates. Cosmopolitan group: Transcontinental (subgroup A), Japanese (subgroup B), West African (subgroup C), North African subgroups (subgroup D). Geographical origin and ethnic origin are described in italics between parenthesis
Serological profile of other infectious agents in samples positive for HTLV-1/2. Marajó Archipelago, Pará, Brazil
| Sample code | 366 | 152 | 243 | 303 | 508 | 688 | 146 | 167 | 180 | 246 | 504 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV | – | – | – | – | – | – | – | – | – | – | – |
| HAV (IgG) | + | – | + | + | – | + | + | + | + | – | – |
| HBV (Anti-Bc) | – | – | – | – | – | – | – | – | + | – | – |
| HCV | – | – | + | – | – | – | – | – | – | – | – |
| CMV (IgG) | + | + | + | + | + | + | + | + | + | + | + |
| Dengue (IgG/IgM) | – | + | + | – | – | – | – | – | IND | – | IND |
| Rubella (IgG/IgM) | + | + | + | + | – | + | + | – | + | + | + |
|
| + | + | – | + | – | + | – | – | + | – | + |
|
| – | + | – | + | – | – | – | – | + | – | – |
|
| IND | – | – | – | IND | – | – | – | – | – | – |
|
| + | + | + | + | – | – | – | – | – | – | – |
HIV human immunodeficiency virus, HAV hepatitis A virus, HBV hepatitis B virus, HCV hepatitis C virus, CMV cytomegalovirus, IND indeterminate result